Ex vivo inhibition of PGE2 formation in human blood by four bicyclico [3.2.1] octane neolignans isolated from Aniba firmula bark, two with unusual structural pattern.

The phytochemical investigation of the stem bark crude extract of Aniba firmula (Lauraceae) led to the isolation of undescribed bicyclic [3.2.1] octane neolignans, 1 and 2, characterized by unusual bicyclic patterns and two other known bicyclic neolignans 3 and 4. Anti-inflammatory bicyclic [3.2.1] octane neolignans metabolites were previously reported in the literature, and the A. firmula stands out in the Lauraceae family as a source of potentially bioactive compounds. Thus, herein the anti-inflammatory potential of four isolated compounds from A. firmula was accessed via an ex vivo anti-inflammatory model that included plasmatic quantification of the prostaglandin E2 (PGE2) inflammatory mediator. Compounds 2 and 3 exhibited significant anti-inflammatory activity by inhibiting the production of PGE2 in plasma samples, thus by interference with the cyclooxygenase (COX) inflammatory pathway. Therefore, these findings demonstrate that the bicyclic octane neolignan classes [3.2.1] can present anti-inflammatory potential.

[1]  M. Soares,et al.  New bicyclic [3.2.1] octane neolignan derivative from Aniba firmula , 2021, Natural product research.

[2]  Wei Li,et al.  Unusual Bicyclo[3.2.1]Octanoid Neolignans from Leaves of Piper crocatum and Their Effect on Pyruvate Dehydrogenase Activity , 2021, Plants.

[3]  J. Lago,et al.  In vivo anti-inflammatory activity of Fabaceae species extracts screened by a new ex vivo assay using human whole blood. , 2021, Phytochemical analysis : PCA.

[4]  J. Lago,et al.  Anti-Inflammatory Derivatives with Dual Mechanism of Action from the Metabolomic Screening of Poincianella pluviosa , 2019, Molecules.

[5]  C. Nakamura,et al.  Antimicrobial substances from Amazonian Aniba (Lauraceae) species , 2019, Natural product research.

[6]  M. Soares,et al.  New bicyclic [3.2.1] octane neolignans derivatives from Aniba firmula with potent in vivo anti-inflammatory activity on account of dual inhibition of PGE2 production and cell recruitment , 2019, Phytochemistry Letters.

[7]  C. Zhan,et al.  Structure-based discovery of mPGES-1 inhibitors suitable for preclinical testing in wild-type mice as a new generation of anti-inflammatory drugs , 2018, Scientific Reports.

[8]  Tong Zhang,et al.  A Metabolomic Approach to Target Compounds from the Asteraceae Family for Dual COX and LOX Inhibition , 2015, Metabolites.

[9]  D. Steinhilber,et al.  Inhibitors of the arachidonic acid cascade: interfering with multiple pathways. , 2014, Basic & clinical pharmacology & toxicology.

[10]  B D Hammock,et al.  Rationally designed multitarget agents against inflammation and pain. , 2013, Current medicinal chemistry.

[11]  M. Sefkow,et al.  COX, LOX and platelet aggregation inhibitory properties of Lauraceae neolignans. , 2009, Bioorganic & medicinal chemistry letters.

[12]  M. Sefkow,et al.  PAF-antagonistic bicyclo[3.2.1]octanoid neolignans from leaves of Ocotea macrophylla Kunth. (Lauraceae). , 2009, Phytochemistry.

[13]  M. Schäfer,et al.  Radical Cations in Electrospray Mass Spectrometry: Formation of Open‐Shell Species, Examination of the Fragmentation Behaviour in ESI‐MSn and Reaction Mechanism Studies by Detection of Transient Radical Cations , 2007 .

[14]  P. Colepicolo,et al.  Radical Ion Generation Processes of Organic Compounds in Electrospray Ionization Mass Spectrometry , 2007 .

[15]  G. Glish,et al.  Electrochemical Origin of Radical Cations Observed in Electrospray Ionization Mass Spectra , 1992 .

[16]  K. Kubitzki,et al.  Chemosystematics of Aniba , 1981 .

[17]  O. Gottlieb,et al.  Bicyclo[3,2,1]octanoid, neolignans from Aniba simulans , 1977 .